Related Experiment Video
Updated: Aug 4, 2026

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
Published on: December 27, 2010
Hereditary hemochromatosis: gene discovery and its implications for population-based screening
W Burke1, E Thomson, M J Khoury
1Department of Medicine, University of Washington, Seattle 98105, USA. wburke@u.washington.edu
Insights
Genetic testing for hereditary hemochromatosis is not recommended for population screening due to uncertainties in HFE gene mutation prevalence and penetrance. Further research is needed to clarify genotype-phenotype correlations and ethical implications.
Area of Science:
- Medical Genetics
- Public Health
- Molecular Biology
Background:
- Hereditary hemochromatosis is a genetic disorder of iron overload.
- The candidate gene HFE is implicated in hemochromatosis.
- Current understanding of HFE mutation prevalence and penetrance is limited.
Framework:
- An expert panel convened by the CDC and NHGRI reviewed evidence on hemochromatosis genetics and testing implications.
- Consensus was achieved through group discussion and a year-long revision process.
- The panel comprised experts in epidemiology, genetics, hepatology, and public health.
Implementation:
- Genetic testing is not currently recommended for population-based screening of hereditary hemochromatosis.
- Concerns exist regarding stigmatization and discrimination associated with genetic screening.
- HFE mutation testing may aid in diagnosing symptomatic individuals but has limitations.
Implications:
- High priority is given to population-based research on HFE mutation prevalence and penetrance.
- Further research should investigate genotype-phenotype correlations and psychosocial outcomes.
- Clarifying these factors is crucial for guiding clinical practice and policy.
Objective:
To evaluate the role of genetic testing in screening for hereditary hemochromatosis to help guide clinicians, policymakers, and researchers.
Participants:
An expert panel was convened on March 3, 1997, by the Centers for Disease Control and Prevention (CDC) and the National Human Genome Research Institute (NHGRI), with expertise in epidemiology, genetics, hepatology, iron overload disorders, molecular biology, public health, and the ethical, legal, and social implications surrounding the discovery and use of genetic information.
Evidence:
The group reviewed evidence regarding the clinical presentation, natural history, and genetics of hemochromatosis, including current data on the candidate gene for hemochromatosis (HFE) and on the ethical and health policy implications of genetic testing for this disorder.
Consensus Process:
Consensus was achieved by group discussion confirmed by a voice vote. A draft of the consensus statement was prepared by a writing committee and subsequently reviewed and revised by all members of the expert group over a 1-year period.
Conclusions:
Genetic testing is not recommended at this time in population-based screening for hereditary hemochromatosis, due to uncertainties about prevalence and penetrance of HFE mutations and the optimal care of asymptomatic people carrying HFE mutations. In addition, use of a genetic screening test raises concerns regarding possible stigmatization and discrimination. Tests for HFE mutations may play a role in confirming the diagnosis of hereditary hemochromatosis in persons with elevated serum iron measures, but even this use is limited by uncertainty about genotype-phenotype correlations. To address these questions, the expert group accorded high priority to population-based research to define the prevalence of HFE mutations, age and sex-related penetrance of different HFE genotypes, interactions between HFE genotypes and environmental modifiers, and psychosocial outcomes of genetic screening for hemochromatosis.
Related Concept Videos
What is Population Genetics?
Hardy-Weinberg Principle
Mutation, Gene Flow, and Genetic Drift
Incomplete Dominance
Single Nucleotide Polymorphisms-SNPs
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

